Investigation of the association between the incidence of G4 neutropenia and patient characteristics revealed a significant difference in pre-treatment liver function values for AST and ALT (P=0.018 and P=0.001, respectively; Table I), between patients with and without severe neutropenia. The gene discussed is GPT; the disease is neutropenia.